New Delhi, Feb 7 (IANS) Union Minister of State for Science and Technology Dr. Jitendra Singh on Friday urged states to establish BioE3 Cells to boost the biotechnology revolution in India and help in realising Bio-Vision for Viksit Bharat by 2047.
He said this during the Centre-State Partnership Conclave on the BioE3 Policy, held at Vigyan Bhavan in Delhi.
“State governments must leverage their unique strengths, resources, and economic priorities to propel India’s biomanufacturing sector forward,” the MoS said.
To ensure the success of the BioE3 Policy, Singh urged states to establish ‘BioE3 Cells’ in collaboration with the Centre through the Department of Biotechnology (DBT).
“These BioE3 Cells will serve as interconnected knowledge hubs, linking state and national stakeholders to facilitate the effective implementation of the BioE3 Policy,” he said.
Established at the state level, these cells will act as central platforms for knowledge exchange, policy coordination, and technology adoption in the bio-manufacturing sector.
At the event, Singh also released a booklet on the ‘Establishment of BioE3 Cells for Biomanufacturing Implementation’, which aims to catalyse Centre-State partnerships to drive biotech innovations.
“The primary goal of the BioE3 Cells is to ensure biomanufacturing initiatives are closely aligned with each state’s specific priorities, resources, and strengths, while also staying connected to broader national objectives,” Singh said.
He emphasised that by establishing a nationwide network of BioE3 Cells, the government aims to facilitate the integration of emerging technologies, innovative research, and sustainable biomanufacturing practices across regions, ensuring a cohesive and efficient approach to biotechnology development in India.
Further, Singh pointed out notable advancements in India’s biotechnology sector, including the indigenous DNA vaccine developed by the Department of Biotechnology during the pandemic, the development of the antibiotic ‘Nafithromycin’, and successful gene therapy trials at CMC Vellore.
The conclave provided a valuable platform for senior representatives from various states to deliberate on biotechnology initiatives, ensuring these efforts are aligned with each state’s unique strengths and resources while staying true to the overarching goals of the BioE3 Policy.
–IANS
rvt/pgh
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
